Market Overview:
The global multi-dose eye dropper market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of eye diseases, rising awareness about eye care, and technological advancements in the field of ophthalmology. Based on type, the global multi-dose eye dropper market is segmented into up to 2ml, 2 to 5 ml, 5 to 10 ml and above 10 ml segments. The up to 2ml segment is expected to account for the largest share of the global multi-dose eye dropper market in 2018 owingto its low cost and easy availability. .
Product Definition:
A multi-dose eye dropper is a device used to administer medication in the form of drops into the eyes. It is important to use a multi-dose eye dropper because it allows for accurate and consistent dosing of medication.
Up to 2ml:
Up to 2ml, it’s usage and growth factor in the multi-dose eye dropper market is driven by factors such as increasing demand for single-use vials due to its convenience and growing R&D activities. Moreover, rising acceptance of up to 2ml eye drop vials due to their cost effectiveness will boost industry growth over the forecast period.
2 to 5 ml:
2 to 5 ml is used for the multi-dose eye dropper. It's a small vial that holds a measured amount of fluid and it's used in ophthalmic (eye) drops. The 2 to 5 ml eye dropper comes with an ampoule containing sterile solution which can be used for multiple doses.
Application Insights:
The adults segment held the largest share of over 70.0% in 2017. The growing geriatric population across the globe is one of the major factors driving this growth. For instance, as per United Nations (UN), there will be about 1,000 thousand people above 60 years of age by 2030 which in turn is expected to create a demand for eye drops among this group. In addition, increasing incidences of myopia and hyperopia are also expected to contribute towards product demand among adults during the forecast period.
The children segment held a significant share owing to rising cases of amblyopia and strabismus worldwide especially in developing countries like India.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing government initiatives, high adoption of advanced technologies, and presence of major players in this region. For instance, as per a survey conducted by National Institutes of Health (NIH), around 40% to 50% of people prefer eye droppers for giving drops instead of using syringes and needles due to their ease and accuracy.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing rising awareness about various treatment options available for vision-related disorders among children & infants as well as adults along with increasing disposable income levels in developing countries such as India & China & Indonesia etc., especially after 2016’s Indian economic reforms plan which include Goods and Services Tax (GST) implemented at 12%, unified nationwide sales tax system across all states/union territories along with other measures like reduction in corporate tax rate from 30%to 25%.
Growth Factors:
- Increasing prevalence of eye diseases: The increasing prevalence of various eye diseases is one of the key growth drivers for the multi-dose eye dropper market. According to a study by The National Eye Institute, around 2 million Americans are affected by blindness and vision impairment every year. This number is expected to increase in the coming years due to the growing population and rising incidence of age-related macular degeneration (AMD) and cataracts. This will create a high demand for multi-dose eyedroppers, which can help in administering timely treatment to patients suffering from these conditions.
- Rising awareness about eye health: There has been a rise in awareness about the importance of good eye health in recent years, owing to which people are increasingly opting for preventive measures such as using multi-dose eyedroppers. Multi-dose eyedroppers offer an easy and convenient way to administer medication directly into the eyes, without having to go through a doctor's appointment or wait in line at an optometry clinic or pharmacy counter. This is likely to boost demand for these products in the coming years.
- Technological advancements: With technological advancements taking place at a rapid pace, there has been an increase in demand for innovative medical devices such as multi-dose eyedroppers that can make treatment easier and more comfortable for patients suffering from various ocular conditions . Manufacturers are focusing on developing advanced products with features such as adjustable dosage levels, ergonomic designs , etc., that can
Scope Of The Report
Report Attributes
Report Details
Report Title
Multi-Dose Eye Dropper Market Research Report
By Type
Up to 2ml, 2 to 5 ml, 5 to 10 ml, Above 10 ml
By Application
Adults, Children, Infants
By Companies
Aero Pump GmbH, Restasis Multidose, Rexam Healthcare Packaging Inc., Adelphi Healthcare Packaging, Gaplast GmbH, TRB Chemedica International SA, Sigan Holdings Inc., Aptar Pharma (India) Pvt. Ltd., Nemera La Verpilliere, Kitch Healthcare India Ltd., Aero Pump GmbH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global Multi-Dose Eye Dropper Market Report Segments:
The global Multi-Dose Eye Dropper market is segmented on the basis of:
Types
Up to 2ml, 2 to 5 ml, 5 to 10 ml, Above 10 ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adults, Children, Infants
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Aero Pump GmbH
- Restasis Multidose
- Rexam Healthcare Packaging Inc.
- Adelphi Healthcare Packaging
- Gaplast GmbH
- TRB Chemedica International SA
- Sigan Holdings Inc.
- Aptar Pharma (India) Pvt. Ltd.
- Nemera La Verpilliere
- Kitch Healthcare India Ltd.
- Aero Pump GmbH
Highlights of The Multi-Dose Eye Dropper Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Up to 2ml
- 2 to 5 ml
- 5 to 10 ml
- Above 10 ml
- By Application:
- Adults
- Children
- Infants
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Multi-Dose Eye Dropper Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A multi-dose eye dropper is a medical device used to dispense medications or other liquids into the eyes.
Some of the key players operating in the multi-dose eye dropper market are Aero Pump GmbH, Restasis Multidose, Rexam Healthcare Packaging Inc., Adelphi Healthcare Packaging, Gaplast GmbH, TRB Chemedica International SA, Sigan Holdings Inc., Aptar Pharma (India) Pvt. Ltd., Nemera La Verpilliere, Kitch Healthcare India Ltd., Aero Pump GmbH.
The multi-dose eye dropper market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Multi-Dose Eye Dropper Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Multi-Dose Eye Dropper Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Multi-Dose Eye Dropper Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Multi-Dose Eye Dropper Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Multi-Dose Eye Dropper Market Size & Forecast, 2018-2028
4.5.1 Multi-Dose Eye Dropper Market Size and Y-o-Y Growth
4.5.2 Multi-Dose Eye Dropper Market Absolute $ Opportunity
Chapter 5 Global Multi-Dose Eye Dropper Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Multi-Dose Eye Dropper Market Size Forecast by Type
5.2.1 Up to 2ml
5.2.2 2 to 5 ml
5.2.3 5 to 10 ml
5.2.4 Above 10 ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Multi-Dose Eye Dropper Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Multi-Dose Eye Dropper Market Size Forecast by Applications
6.2.1 Adults
6.2.2 Children
6.2.3 Infants
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Multi-Dose Eye Dropper Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Multi-Dose Eye Dropper Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Multi-Dose Eye Dropper Analysis and Forecast
9.1 Introduction
9.2 North America Multi-Dose Eye Dropper Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Multi-Dose Eye Dropper Market Size Forecast by Type
9.6.1 Up to 2ml
9.6.2 2 to 5 ml
9.6.3 5 to 10 ml
9.6.4 Above 10 ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Multi-Dose Eye Dropper Market Size Forecast by Applications
9.10.1 Adults
9.10.2 Children
9.10.3 Infants
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Multi-Dose Eye Dropper Analysis and Forecast
10.1 Introduction
10.2 Europe Multi-Dose Eye Dropper Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Multi-Dose Eye Dropper Market Size Forecast by Type
10.6.1 Up to 2ml
10.6.2 2 to 5 ml
10.6.3 5 to 10 ml
10.6.4 Above 10 ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Multi-Dose Eye Dropper Market Size Forecast by Applications
10.10.1 Adults
10.10.2 Children
10.10.3 Infants
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Multi-Dose Eye Dropper Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Multi-Dose Eye Dropper Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Multi-Dose Eye Dropper Market Size Forecast by Type
11.6.1 Up to 2ml
11.6.2 2 to 5 ml
11.6.3 5 to 10 ml
11.6.4 Above 10 ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Multi-Dose Eye Dropper Market Size Forecast by Applications
11.10.1 Adults
11.10.2 Children
11.10.3 Infants
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Multi-Dose Eye Dropper Analysis and Forecast
12.1 Introduction
12.2 Latin America Multi-Dose Eye Dropper Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Multi-Dose Eye Dropper Market Size Forecast by Type
12.6.1 Up to 2ml
12.6.2 2 to 5 ml
12.6.3 5 to 10 ml
12.6.4 Above 10 ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Multi-Dose Eye Dropper Market Size Forecast by Applications
12.10.1 Adults
12.10.2 Children
12.10.3 Infants
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Multi-Dose Eye Dropper Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Multi-Dose Eye Dropper Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Multi-Dose Eye Dropper Market Size Forecast by Type
13.6.1 Up to 2ml
13.6.2 2 to 5 ml
13.6.3 5 to 10 ml
13.6.4 Above 10 ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Multi-Dose Eye Dropper Market Size Forecast by Applications
13.10.1 Adults
13.10.2 Children
13.10.3 Infants
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Multi-Dose Eye Dropper Market: Competitive Dashboard
14.2 Global Multi-Dose Eye Dropper Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Aero Pump GmbH
14.3.2 Restasis Multidose
14.3.3 Rexam Healthcare Packaging Inc.
14.3.4 Adelphi Healthcare Packaging
14.3.5 Gaplast GmbH
14.3.6 TRB Chemedica International SA
14.3.7 Sigan Holdings Inc.
14.3.8 Aptar Pharma (India) Pvt. Ltd.
14.3.9 Nemera La Verpilliere
14.3.10 Kitch Healthcare India Ltd.
14.3.11 Aero Pump GmbH
